Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
Xiao R, Tian Y, Zhang J, Li N, Qi M, Liu L, Wang J, Li Z, Zhang J, Zhao F, Wang T, Tan S, Li C, Wu Z, Yu M, Jiang X, Zhan P, Gao L, Han B, Liu X, Liang X, Ma C.
Xiao R, et al. Among authors: liang x.
J Hepatol. 2024 May;80(5):792-804. doi: 10.1016/j.jhep.2024.01.028. Epub 2024 Feb 7.
J Hepatol. 2024.
PMID: 38331327